Juno Therapeutics overview

Juno Therapeutics is a biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute.
The average employee at Juno Therapeutics makes $79,550 per year. Pay at Juno Therapeutics is significantly lower than some of its highest paying competitors, like Gilead Sciences, Amgen, and Biogen, which pay $95,385, $92,091, and $91,058, respectively.
Juno Therapeutics is a medium technology company with 554 employees and an annual revenue of $82.6M that is headquartered in Seattle, Washington.

The Organization’s Mission

Our mission is based on a belief that cell therapy can become a third pillar of medicine, to revolutionize the way cancer is treated.


Health Care





Founded in



Seattle, WA



Organization Type


Is This Your Company?

The team at Juno Therapeutics

Key People
  • Robert Azelby (Executive Officer)
  • Anthony Evnin (Director)
  • Bernard Cassidy (Executive Officer)
  • Mary Wilderotter (Director)
  • Howard Pien (Director)
  • Thomas Daniel (Director)
  • Robert Nelsen (Director, Promoter)
  • Jay Flatley (Director)
  • Sunil Agarwal (Executive Officer)
  • Steven Harr (Executive Officer)
  • Richard Klausner (Director, Promoter)
  • Hans Bishop (ceo)
  • Rupert Vessey (Director)
  • Hal Barron (Director)

What do people say about Juno Therapeutics

Work at Juno Therapeutics ? Share your experience anonymously.

What do you like about working for Juno Therapeutics?

Juno Therapeutics Rankings

Juno Therapeutics is ranked #19 on the Best Health Care Companies to Work For in Washington list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Juno Therapeutics Salaries

How much does Juno Therapeutics pay?
The national average salary for a Juno Therapeutics employee in the United States is $79,550 per year. Employees in the top 10 percent can make over $141,000 per year, while employees at the bottom 10 percent earn less than $44,000 per year.
Salary Score
Average Employee Earnings

Juno Therapeutics Salaries By Job Title

While the average employee salary at Juno Therapeutics is $79,550, there is a big variation in pay depending on the role. The higher paying positions at Juno Therapeutics include Principal Developer, Demand Planning Manager, Senior Engineering Team Leader, and Principal Scientist. A typical Principal Developer salary at Juno Therapeutics is $116,552 per year. To get a better sense of the salaries at Juno Therapeutics, other roles such as Manufacturing Associate and Manufacturing Technician can be considered as well. For comparison, the title Manufacturing Associate at Juno Therapeutics earns $37,771 per year.

Do you Work At Juno Therapeutics?

Help us make this company more transparent.


Juno Therapeutics Financial Performance

Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.


$10M - $100M

Founded in


Organization type


Juno Therapeutics Financing Rounds

DateAmountSecurity Type
Oct 5, 2017Equity
Oct 5, 2017
Aug 14, 2014Equity
Aug 14, 2014
May 8, 2014Equity
May 8, 2014
Dec 26, 2013Equity
Dec 26, 2013

How Would You Rate The Company Culture Of Juno Therapeutics?

Have you worked at Juno Therapeutics? Help other job seekers by rating Juno Therapeutics.

Juno Therapeutics Competitors

Some of the competitors of Juno Therapeutics are Gilead Sciences, Amgen, and Biogen. The wages at Gilead Sciences average higher than the other similar companies, where the median salary is $95,385 per year. Employees at Amgen earn an average of $92,091 per year, and the employees at Biogen earn an average salary of $91,058 per year.
Average Salary

Frequently Asked Questions about Juno Therapeutics

When was Juno Therapeutics founded?

Juno Therapeutics was founded in 2013.

How many Employees does Juno Therapeutics have?

Juno Therapeutics has 554 employees.

How much money does Juno Therapeutics make?

Juno Therapeutics generates $82.6M in revenue.

What industry is Juno Therapeutics in?

Juno Therapeutics is in the health care industry.

What is Juno Therapeutics's mission?

Juno Therapeutics's mission statement is "Our mission is based on a belief that cell therapy can become a third pillar of medicine, to revolutionize the way cancer is treated."

What type of company is Juno Therapeutics?

Juno Therapeutics is a public company.

Who are Juno Therapeutics's competitors?

Juno Therapeutics competitors include Repligen, Amgen, Gilead Sciences, Biogen, Organovo, Ardelyx, Osiris Therapeutics, Kite Pharma, Novavax, Agenus, Intellia Therapeutics, Neurocrine Biosciences, Vital Therapies, Alkermes, FibroGen, Regulus Therapeutics, Agios Pharmaceuticals, XBiotech, MacroGenics, Epizyme.

Who works at Juno Therapeutics?

Robert Azelby (Executive Officer)

Anthony Evnin (Director)

Bernard Cassidy (Executive Officer)

Show More

Are you an executive, HR leader, or brand manager at Juno Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at Juno Therapeutics, also known as JUNO THERAPEUTICS INC, Juno Therapeutics, Juno Therapeutics Inc and Juno Therapeutics, Inc..

Zippia gives an in-depth look into the details of Juno Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Juno Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Juno Therapeutics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Juno Therapeutics and its employees or that of Zippia.